Balentine LLC’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,072
| Closed | -$680K | – | 210 |
|
|
2025
Q1 | $680K | Buy |
+1,072
| New | +$680K | 0.03% | 92 |
|
|
2024
Q2 | – | Sell |
-3,278
| Closed | -$3.16M | – | 479 |
|
|
2024
Q1 | $3.16M | Sell |
3,278
-121
| -4% | -$116K | 0.09% | 70 |
|
|
2023
Q4 | $2.99M | Buy |
3,399
+97
| +3% | +$85.2K | 0.1% | 75 |
|
|
2023
Q3 | $2.72M | Buy |
3,302
+45
| +1% | +$37K | 0.09% | 68 |
|
|
2023
Q2 | $2.34M | Buy |
3,257
+32
| +1% | +$23K | 0.08% | 75 |
|
|
2023
Q1 | $2.65M | Sell |
3,225
-391
| -11% | -$321K | 0.09% | 78 |
|
|
2022
Q4 | $2.61M | Buy |
3,616
+405
| +13% | +$292K | 0.09% | 80 |
|
|
2022
Q3 | $2.21M | Sell |
3,211
-655
| -17% | -$451K | 0.08% | 72 |
|
|
2022
Q2 | $2.29M | Buy |
3,866
+1,587
| +70% | +$938K | 0.08% | 96 |
|
|
2022
Q1 | $1.59M | Buy |
2,279
+1,652
| +263% | +$1.15M | 0.05% | 105 |
|
|
2021
Q4 | $396K | Buy |
627
+44
| +8% | +$27.8K | 0.01% | 202 |
|
|
2021
Q3 | $353K | Buy |
+583
| New | +$353K | 0.01% | 160 |
|
|
2020
Q3 | – | Sell |
-99
| Closed | -$62K | – | 694 |
|
|
2020
Q2 | $62K | Buy |
99
+9
| +10% | +$5.64K | ﹤0.01% | 210 |
|
|
2020
Q1 | $44K | Buy |
90
+86
| +2,150% | +$42K | ﹤0.01% | 191 |
|
|
2019
Q4 | $2K | Hold |
4
| – | – | ﹤0.01% | 543 |
|
|
2019
Q3 | $1K | Sell |
4
-3
| -43% | -$750 | ﹤0.01% | 713 |
|
|
2019
Q2 | $2K | Buy |
+7
| New | +$2K | ﹤0.01% | 645 |
|
|
2018
Q1 | – | Sell |
-31
| Closed | -$12K | – | 420 |
|
|
2017
Q4 | $12K | Sell |
31
-27
| -47% | -$10.5K | ﹤0.01% | 448 |
|
|
2017
Q3 | $26K | Hold |
58
| – | – | ﹤0.01% | 358 |
|
|
2017
Q2 | $28K | Hold |
58
| – | – | ﹤0.01% | 324 |
|
|
2017
Q1 | $22K | Buy |
58
+31
| +115% | +$11.8K | ﹤0.01% | 331 |
|
|
2016
Q4 | $10K | Hold |
27
| – | – | ﹤0.01% | 409 |
|
|
2016
Q3 | $11K | Hold |
27
| – | – | ﹤0.01% | 350 |
|
|
2016
Q2 | $9K | Buy |
+27
| New | +$9K | ﹤0.01% | 365 |
|
|
2016
Q1 | – | Sell |
-74
| Closed | -$40K | – | 386 |
|
|
2015
Q4 | $40K | Buy |
+74
| New | +$40K | 0.01% | 175 |
|